Ledger.Open graph →
SEC Form D · filed November 10, 2020

Elucida Oncology, Inc

Offering
$35.0M
Sold
$17.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Monmouth Junction, NJ
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Kai Ma · Monmouth Junction, NJExecRobert Essner · Monmouth Junction, NJExec · DirectorEliel Bayever · Monmouth Junction, NJExecMichael Smith · Monmouth Junction, NJDirectorGregory Adams · Monmouth Junction, NJExecTim Boris · Monmouth Junction, NJDirectorGeno Germano · Monmouth Junction, NJExec · DirectorTeresa Ressel · Monmouth Junction, NJDirectorRobert Ruffolo · Monmouth Junction, NJDirectorUlrich Wiesner · Monmouth Junction, NJDirectorJosh Froelich · Houston, TXExecJakub Rehor · Reno, NVExecJohn M. Courtright · Elmhurst, ILDirectorJan F. Van Eck · New York, NYDirectorMichael Wolfgramm · Orem, UTExec · DirectorRalph Yarro · Orem, UTDirectorJonathan R. Simon · New York, NYDirectorKasper Bihlet · Houston, TXExecAyman M. Shahin · Dubai, C0DirectorSpencer Patterson · Orem, UTExec · DirectorDavid Anthony · Broomfield, CODirectorJanice Craig · Vancouver, British Columbia, CanadaDirectorDion F. Chu · New York, NYExec · DirectorMichael F. Peng · New York, NYDirectorHelene Servillon · Dover, DEExec · DirectorKara Forney · Albuquerque, NMDirectorDane F. Lund · New York, NYDirectorVictor D. Woolridge · New York, NYExecJonathan Lamm · New York, NYExecMelissa Weiler · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗